http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100704008-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4cb26f8307345d9bc4c3c63b68b8b4b7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
filingDate 2005-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a96c0b4ccba6e9f8e6745be6d8842ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f17487daff7fc9e5e2ed04980d29a02f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf05f6c8ace58e3fc26c947121e17874
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ea905608bc7d63db27d263f3d211255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8b82d5ad292016e95a2f75c600dd8cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ba24e89a9a6eb7427c46c700e765c7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_539581a1ab2f26adc90ff5edcead8e8b
publicationDate 2007-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100704008-B1
titleOfInvention Oral preparations containing silinidipine and preparation method thereof
abstract The present invention relates to oral preparations containing silinidipine and a method for preparing the same. More specifically, the present invention relates to α-hydro-ω-hydroxypoly (oxyethylene) in order to increase bioavailability of the antihypertensive agent silnidipine which is poorly soluble in water. Solubilized solid dispersion using a poly (oxypropylene) poly (oxyethylene) block copolymer [α-Hydro-ω-hydroxypoly (oxyethylene) poly (oxypropylene) poly (oxyethylene) block copolymer, Poloxamer] as a solubilizer and binder The present invention relates to an oral preparation and a method for preparing the same, which are powdered using a stabilizer in a sieve, and mixed with a disintegrant, which does not require the use of a solvent as compared to the prior art, and thus can be formulated with high productivity.n n n n Silnidipine, solubilizer, polymer base, stabilizer, disintegrant
priorityDate 2005-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20050071888-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040006887-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21881395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452716272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449751318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448783041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25199638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547

Total number of triples: 54.